pcv13 serotypes | About Pneumococcal Vaccine: For Providers

Keyword	CPC	PCC	Volume	Score	Length of keyword
pcv13 serotypes	0.8	0.7	5866	13	15
pcv13	0.03	0.3	2328	72	5
serotypes	1.73	0.8	967	70	9

Keyword	CPC	PCC	Volume	Score
pcv13 serotypes	0.58	1	7305	67
pcv15 serotypes	0.07	0.9	5331	84
pcv13 serotype prevalence	1.01	0.9	3536	77
what serotypes are in pcv13	0.77	0.3	5380	19
merck pcv15 serotypes	1.67	0.6	4516	48

Search Results related to pcv13 serotypes on Search Engine

About Pneumococcal Vaccine: For Providers | CDC
cdc.gov

https://www.cdc.gov/vaccines/vpd/pneumo/hcp/about-vaccine.html

WEBStudies showed PCV13 induced antibody levels comparable to those induced by PCV7 and shown to be protective against invasive disease. Substantial evidence demonstrates routine infant PCV7 and PCV13 vaccination reduced pneumococcal carriage and transmission of vaccine serotypes.

DA: 13 PA: 39 MOZ Rank: 82

Prevnar 13 | FDA - U.S. Food and Drug Administration
fda.gov

https://www.fda.gov/vaccines-blood-biologics/vaccines/prevnar-13

WEBActive immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in children 6 weeks through 5 years...

DA: 24 PA: 13 MOZ Rank: 67

Pneumococcal Vaccine - StatPearls - NCBI Bookshelf
nih.gov

https://www.ncbi.nlm.nih.gov/books/NBK507794/

WEBMar 20, 2023 · PCV13 (13-valent pneumococcal conjugate vaccine): PCV 13 provides active immunization against serotypes of Streptococcus pneumoniae (1, 3, 4, 5, 6A and 6B, 7F, 9V, 14, 19A, and 19F, 18C, and 23F). Indications vary according to age.

DA: 12 PA: 84 MOZ Rank: 72

Pinkbook: Pneumococcal Disease | CDC
cdc.gov

https://www.cdc.gov/vaccines/pubs/pinkbook/pneumo.html

WEBPCV13 contains 13 serotypes of S. pneumoniae (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) conjugated to a nontoxic variant of diphtheria toxin known as CRM197. PCV13 is administered by intramuscular injection.

DA: 97 PA: 87 MOZ Rank: 23

Package Insert - Prevnar 13 - U.S. Food and Drug …
fda.gov

https://www.fda.gov/files/vaccines%2C%20blood%20%26%20biologics/published/Package-Insert------Prevnar-13.pdf

WEBactive immunization for the prevention of invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and. 23F. (1.2) In adults 18 years of age and older,...

DA: 53 PA: 6 MOZ Rank: 62

13-valent pneumococcal conjugate vaccine (PCV13) - PubMed
nih.gov

https://pubmed.ncbi.nlm.nih.gov/21941097/

WEBPCV13 consists of thirteen pneumococcal capsular polysaccharides individually conjugated to the diphtheria-derived protein carrier CRM (197). In addition to serotypes 4, 6B, 9V, 14, 18C, 19F and 23F included in PCV7, PCV13 also includes serotypes 1, 3, 5, 6A, 7F and 19A.

DA: 1 PA: 1 MOZ Rank: 95

Pneumococcal Vaccination: What Everyone Should Know | CDC
cdc.gov

https://www.cdc.gov/vaccines/vpd/pneumo/public/index.html

WEBStudies showed PCV13 prevented invasive pneumococcal disease caused by vaccine serotypes: Getting at least one PCV13 shot protected 4 in 5 healthy children; Getting at least one PCV13 shot protected 4 in 5 children with a risk condition; PCV13 also prevented antimicrobial-resistant pneumococcal infections caused by vaccine serotypes.

DA: 10 PA: 33 MOZ Rank: 41

PCV13 Vaccination of Adults against Pneumococcal Disease: What …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778913/

WEBJan 8, 2022 · PCV13 is a 13-valent conjugate vaccine that contains capsular polysaccharides from serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F individually conjugated to genetically detoxified diphtheria toxin, CRM197, by reductive amination.

DA: 98 PA: 33 MOZ Rank: 86

Efficacy and Effectiveness of the PCV-10 and PCV-13 Vaccines …
aap.org

https://publications.aap.org/pediatrics/article/145/4/e20190377/36954/Efficacy-and-Effectiveness-of-the-PCV-10-and-PCV

WEBApr 1, 2020 · In children <12 months of age, PCV-13 VE against serotype 19A post–primary series was significant for the 3 + 1 but not the 2 + 1 schedule. PCV-10 crossprotection against 19A was significant in children ≤5 years with ≥1 dose (82.2% and 71%). The majority of studies did not find either PCV to be effective against serotype-3.

DA: 30 PA: 69 MOZ Rank: 6

Immunogenicity and seroefficacy of 10-valent and 13-valent …
thelancet.com

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00250-X/fulltext

WEBJul 1, 2023 · GMRs comparing PCV13 vs PCV10 favoured PCV13 for serotypes 4, 9V, and 23F at 1 month after primary vaccination series, with 1.14- to 1.54- fold significantly higher IgG responses with PCV13. Risk of seroinfection prior to the time of booster dose was lower for PCV13 for serotype 4, 6B, 9V, 18C and 23F than for PCV10.

DA: 6 PA: 49 MOZ Rank: 60